refine.bio helps you build ready-to-use datasets with normalized transcriptome data from all of the world’s genetic databases.
GSE89932
Identification of genes that are modulated by BET inhibitors in cancer cells to identify robust pharmacodynamic marker for monitoring target engagement of BET family bromodomain inhibitors in tumors and surrogate tissue
Homo sapiens
35 Downloadable Samples
Affymetrix Human Genome U133A 2.0 Array (hgu133a2)
Submitter Supplied Information
Description
Competitive inhibitors of acetyl-lysine binding to the bromodomains of the BET (bromodomain and extra terminal) family are being developed for the treatment of solid and heme malignancies. BET family member BRD4 function at enhancers/super-enhancers has been shown to sustain signal-dependent or pathogenic gene expression programs.